VeriMomhexapeptide-12 hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
Pregnancy-safe products containing hexapeptide-12
Related ingredients
Frequently asked questions
- hexapeptide-12 hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
- hexapeptide-12 emzirirken güvenli mi?
- No data indicating reproductive or lactation toxicity, no mechanistic evidence for transfer into breastmilk, and no harmonised classifications. With no demonstrated systemic bioavailability from topical use, breastfeeding exposure is considered negligible. Sources: SCCS/CIR (no opinion), PubMed (no lactation studies), PubChem/CosIng (no hazard data).
- hexapeptide-12 bebek cildi için güvenli mi?
- No infant-specific toxicity or developmental data identified. Hazard and mechanism remain 0 due to lack of evidence or harmonised classification. Dermal exposure score increased by +1 for baby skin (to 1) because peptides are not completely non‑absorbable and infant skin has a higher surface-area-to-weight ratio and immature barrier, so a low but measurable exposure is plausible even if adult absorption is negligible. Sources: general dermal absorption principles (peptide physicochemistry), CosIng/PubChem (ingredient listings), PubMed (no infant studies).
- VeriMom hexapeptide-12 nasıl puanlıyor?
- VeriMom hexapeptide-12'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hexapeptide-12 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.